Metastatic Colorectal Cancers Not Yet Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03401294Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.Treatment